Evidence map›Paper›PMID 25780046›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia.

Bo Liu, Jee-Boong Lee, Chun-Yu Chen, Gurjit K Khurana Hershey, Yui-Hsi Wang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Crosstalk between ILC2s and Th2 CD4Journal of immunology research · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Th9 Cells in Allergic Disease.Current allergy and asthma reports · 2019
    Review
  15. Review
  16. Review
  17. Review
  18. ICAM-1 controls development and function of ILC2.The Journal of experimental medicine · 2018
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Bo LiuDivision of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45220;
Jee-Boong LeeDivision of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45220;
Chun-Yu ChenDivision of Hematology, Oncology, and Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH 43205; and.
Gurjit K Khurana HersheyDivision of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45220.
Yui-Hsi WangDivision of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45220; yui_hsi.wang@cchmc.org.
Cincinnati Children's Hospital Medical Center · USNationwide Children's Hospital · US

Funding

Regulation of TH2 memory/effector cells during allergic inflammationR01AI090129 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI WANG, YUI-HSI · 2010 to 2014
$1.9M
NIAID NIH HHS AI090129NIAID NIH HHS AI-169584-NNIAID NIH HHS R01 AI090129
6 · The paper itself

Abstract

Type-2 innate lymphoid cells (ILC2s) and the acquired CD4(+) Th2 and Th17 cells contribute to the pathogenesis of experimental asthma; however, their roles in Ag-driven exacerbation of chronic murine allergic airway diseases remain elusive. In this study, we report that repeated intranasal rechallenges with only OVA Ag were sufficient to trigger airway hyperresponsiveness, prominent eosinophilic inflammation, and significantly increased serum OVA-specific IgG1 and IgE in rested mice that previously developed murine allergic airway diseases. The recall response to repeated OVA inoculation preferentially triggered a further increase of lung OVA-specific CD4(+) Th2 cells, whereas CD4(+) Th17 and ILC2 cell numbers remained constant. Furthermore, the acquired CD4(+) Th17 cells in Stat6(-/-)/IL-17-GFP mice, or innate ILC2s in CD4(+) T cell-ablated mice, failed to mount an allergic recall response to OVA Ag. After repeated OVA rechallenge or CD4(+) T cell ablation, the increase or loss of CD4(+) Th2 cells resulted in an enhanced or reduced IL-13 production by lung ILC2s in response to IL-25 and IL-33 stimulation, respectively. In return, ILC2s enhanced Ag-mediated proliferation of cocultured CD4(+) Th2 cells and their cytokine production, and promoted eosinophilic airway inflammation and goblet cell hyperplasia driven by adoptively transferred Ag-specific CD4(+) Th2 cells. Thus, these results suggest that an allergic recall response to recurring Ag exposures preferentially triggers an increase of Ag-specific CD4(+) Th2 cells, which facilitates the collaborative interactions between acquired CD4(+) Th2 cells and innate ILC2s to drive the exacerbation of a murine allergic airway diseases with an eosinophilic phenotype.

Indexed as

Immunity, InnateAnimalsAsthmaCell CommunicationInflammationInterleukin-33InterleukinsMiceMice, Inbred BALB CMice, KnockoutOvalbuminPulmonary EosinophiliaSTAT6 Transcription FactorTh17 CellsTh2 CellsIl33 protein, mouseInterleukin-33InterleukinsMydgf protein, mouseOvalbuminStat6 protein, mouseSTAT6 Transcription Factor

Identifiers

PMID25780046
PMCPMC4390517
OpenAlexW1566116845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.